期刊文献+

反义寡核苷酸技术在肿瘤中的应用研究进展 被引量:2

原文传递
导出
摘要 随着分子生物学的迅猛发展,基因技术已应用于肿瘤研究领域,反义寡核苷酸(ASODN)技术具有特异性高、副作用少的特点,发展迅速,已逐渐从实验室走向临床。本文对反义寡核苷酸技术的作用机制、设计及在肿瘤中的研究应用等方面作一综述,并提出目前该领域存在的问题及其应用前景。
出处 《国际泌尿系统杂志》 2009年第1期35-38,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献3

二级参考文献14

  • 1[1] Sakakura C,Hagiwara A,Tsujimoto H,et al. Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen[J]. Br J Cancer, 1994,70(6):1060~1066.
  • 2[2] Sakakura C,Hagiwara A,Tsujimoto H,et al. The anti-proliferative effect of proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines[J]. Surg Today, 1995,25(2):184~186.
  • 3[3] Taniai M,Toimatsu M,Okuda H. Immunohistochemical detection of proliferating nuclear antigen in hepatocellular carcinoma relationship to histological grade[J]. J Gastrenterol Hepatol, 1993,8:420~425.
  • 4[5] Jaskulski D,Deriel JK,Mercer WE,et al. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin[J]. Science, 1988,240:1544~1546.
  • 5[6] 鄂 征. 组织培养和分子细胞学技术[M]. 第2版. 北京:北京出版社, 1997.155.
  • 6[7] Stein CA.Phosphorothioate antisense oligodeoxynucleotides:questions of specificity[J]. Trends Biotechnol, 1996,14(5):147.
  • 7Sakata K, Shigemasa K, Nagai N, et al, Expression of matrix metalloproteinases (MMP-2, MMP-9, MTI-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Int J Oncol, 2000, 17: 673-681.
  • 8Lengyel E, Schmalfeldt B, Konik E, et al, Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol, 2001, 82: 291-298.
  • 9Kleiner D, Stetler-Stevenson W. Matrix metalloproteinases and metastasis, Cancer Chemother Phamacol, 1999, 43 (suppl) : s42-51.
  • 10史宪杰,李开宗,窦科峰,刘刚,张传山,王文亮.增殖细胞核抗原在肝硬化、肝细胞不典型增生和肝细胞癌中的表达及意义[J].中华实验外科杂志,1998,15(5):412-413. 被引量:8

共引文献24

同被引文献19

  • 1唐古生,蔡建明,倪瑾,项莺松,崔建国,朱丹,董俊瑞.反义STAT3对肿瘤细胞增殖抑制和诱导凋亡的作用[J].癌症,2006,25(3):269-274. 被引量:18
  • 2Masciocchi D, Gelain A, Villa S, et al. Signal transducer and acti- vator of transcription 3 ( STAT3 ) : a promising target for anticancer therapy [J]. Future Med Chem, 2011,3(5) :567-597.
  • 3Jing N, Li Y, Xiong W, et al. G-quartet oligonucleotides: a new class of signal transducer and activator oftranscription 3 inhibitors that suppresses growth of prostate and breast tumors through induc- tion of apoptosis [J]. Cancer Res, 2004,64(18) :6603-6609.
  • 4Sun M, Liu C, Nadiminty N, et al. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion [J]. Prostate, 2012,72( 1 ) :82-89.
  • 5Levy DE, Inghirami G. STAT3 : a muhifaceted oncogene [ J]. Proc Natl Acad Sci U S A, 2006,103(27) :10151-10152.
  • 6Huang C, Cao J, Huang K J, et al. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer ceils in vitro [J]. Cancer Sci, 2006,97(12) :1417-1423.
  • 7Xiong H, Zhang ZG, Tian XQ, et al. Inhibition of JAK1, 2/ STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells [ J]. Neoplasia, 2008,10( 3 ) :287-297.
  • 8Silver DL, Naora H, Liu J, et al. Activated signal transducer and activator of transcription (STAT) 3 : localization in focal adhesion and function in ovarian cancer cell motility [J]. Cancer Res, 2004,64(10) :3550-3558.
  • 9赵时梅,杨燕初.信号转导和转录激活因子3在宫颈癌中的研究进展[J].医学综述,2010,16(7):1022-1024. 被引量:2
  • 10李晓蕾,王霞,周军红,赵爱琳.宫颈癌组织STAT3和MMP-2表达及意义[J].齐鲁医学杂志,2011,26(4):298-301. 被引量:4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部